The association between AR expression and patients' survival was previously studied in TCGA datasets, where high AR mRNA and protein expression was a negative prognostic factor in low‐grade glioma [11], a finding we could not confirm when analysing IDH mutated glioma. The gene discussed is AR; the disease is glioma.